4CE is an international consortium for electronic health record (EHR) data-driven studies of the COVID-19 pandemic. The goal of this effort—led by the i2b2 international academics users group—is to inform doctors, epidemiologists and the public about COVID-19 patients with data acquired through the health care process.
Phase 1 Results
Results from the first phase of data acquisition and analysis have been published to npj Digital Medicine, "International Electronic Health Record-Derived COVID-19 Clinical Course Profile: The 4CE Consortium."
Phase 1.1 Main Results
Results from Phase 1.1 of data acquisition and analysis have been submitted to medRxiv as a preprint, "International Comparisons of Harmonized Laboratory Value Trajectories to Predict Severe COVID-19: Leveraging the 4CE Collaborative Across 342 Hospitals and 6 Countries: A Retrospective Cohort Study."
Phase 1.1 Severity Definition Results
Results from the severity definition process during Phase 1.1 have been submitted to medRxiv as a preprint, "Validation of a Derived International Patient Severity Phenotype to Support COVID-19 Analytics from Electronic Health Record Data."
Joining the Consortium
If you are interested in joining the 4CE project, please visit the join page.